2021 | Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score
https://pmccbiobank.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 sabrina.agostini@uhn.ca sabrina.agostini@uhn.ca https://secure.gravatar.com/avatar/b61021141fafd1778f9d8d649e43b1e9?s=96&d=mm&r=g
Short Description: Atrial fibrillation (AF) is the most common sustained arrhythmia in hypertrophic cardiomyopathy (HCM), associated with impaired quality of life, risk for embolic stroke, and unpredictable onset. We sought to create a predictive model to identify risk for AF development in HCM.
Interest: Atrial Fibrillation, Hypertrophic Cardiomyopathy
Click Here to Read the Full Publication